NYSE · HCA
HCA Healthcare, Inc.
Healthcare · Medical - Care Facilities
$467.53▼ 0.32% ($1.50)today
As of 12:13 PM ET
Valuation
Cash-flow DCF
Verdict: fairly priced. Price between Bear and Base.
The price holds with free cash flow shrinking 4.7% a year for 5 years. Our scenarios assume −4.6–25.0%.
That's below its past 10-year pace of 10.4%.
Value per share
Base case
$1,130.82
Price used $467.53 is 59% below this
USD · TTM ending Jun 30, 2026 · Price Oct 26, 4:13 PM UTC
FCFF base normalized by replacing latest capex with the company's trailing median capex-to-revenue ratio.
2 more notes
Historical FCFF CAGR and the default growth rates are taken from the raw historical series. The valuation base is normalized for the current-period DCF.
Reported total debt includes capitalised leases (~4% of the total). They are excluded from net debt and from the WACC weights because rent is already charged inside operating income. The Net Debt shown here is therefore lower than the balance-sheet figure elsewhere on this page.
Free cash flow each value needs
Free cash flow today $9.4B. The price needs $9.8B by 2036. Base case: $20.3B. At its recent pace: $25.2B. Bear to Bull: $8.8B to $54.6B.
Free cash flow today $9.4B. The price needs $9.8B by 2036. Base case: $20.3B. At its recent pace: $25.2B. Bear to Bull: $8.8B to $54.6B.
Free cash flow in 2036
today $9.4B
−$10.5Bless than the Base case
Value per share · Base case
$1,130.82
Price $467.53
59% below this
- Stage 1 growth, yrs 1–5
- 10.4%
- Stage 2 growth, yrs 6–10
- 5.7%
- Discount rate
- 7.9%
FCFF base normalized by replacing latest capex with the company's trailing median capex-to-revenue ratio.
2 more notes
Historical FCFF CAGR and the default growth rates are taken from the raw historical series. The valuation base is normalized for the current-period DCF.
Reported total debt includes capitalised leases (~4% of the total). They are excluded from net debt and from the WACC weights because rent is already charged inside operating income. The Net Debt shown here is therefore lower than the balance-sheet figure elsewhere on this page.
USD · TTM ending Jun 30, 2026 · Price Oct 26, 4:13 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 0.1% over the last year. Revenue grew 7.31% over the trailing twelve months. Operating margin moved from 15.24% to 15.48%. Free cash flow declined 17.76% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 15.48%. A decisive move in revenue — currently up 7.31% — would be the clearest signal to resolve the ambiguity.
Return analysis
Company profile
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States.
Market multiples
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
29
Buy
15
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Oct 27, 2026
Q3 FY26 · EPS est $6.65 · Revenue est $19.3B
Same quarter, year over year
FY26 YTD +10.9%Each cell vs the same quarter a year earlier (the cell below) · Q1–Q2 combined $14.74 vs $13.29 · all 2 quarters up
Q1
Q2
Q3
Q4
FY total
FY26
—
—
FY25
FY24
FY23
—
—
—
Fiscal year totals
- FY25
- $28.26
- +24.4%
- FY24
- $22.71
- —
Q2 FY26
Reported Jul 24, 2026 · Latest
HoverTap a cell to inspect
Actual
$7.59
Estimate
$7.56
Year over year
+11.0%
Vs prior quarter
+6.2%
Institutional Sentiment
HCA Healthcare, Inc. · HCA
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.